RENEE CARNEY: Open Payments
NPI 1194492538 · ILION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 55 payments from 23 companies in 2025. Trend: 2023 $247 · 2024 $717 · 2025 $1,477
Food & beverage: $1,203Education: $274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $224 |
| Daiichi Sankyo Inc. | 6 | $208 |
| ABBVIE INC. | 5 | $194 |
| Lilly USA, LLC | 7 | $136 |
| Incyte Corporation | 1 | $96 |
| Merck Sharp & Dohme LLC | 3 | $81 |
| Janssen Biotech, Inc. | 3 | $74 |
| Novo Nordisk Inc | 2 | $47 |
| Amgen Inc. | 3 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: Enhertu, AIRSUPRA, IMBRUVICA, MOUNJARO, KEYTRUDA, OTEZLA, JARDIANCE, XIFAXAN.
Industry payments across NY — which companies pay providers there.
